Risk of allogeneic transfusions

British Journal of Anaesthesia

Volumn 81, Issue SUPPL. 1, 1998, Pages 16-19

  Heiss, Markus M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Blood, transfusion; Immune response

Indexed keywords

BLOOD TRANSFUSION; CANCER SURGERY; CONFERENCE PAPER; DISEASE TRANSMISSION; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; MORBIDITY; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; RISK;

BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; HUMANS; IMMUNE TOLERANCE; NEOPLASMS; OPPORTUNISTIC INFECTIONS; POSTOPERATIVE COMPLICATIONS;

EID: 0031743924     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Heiss MM, Delanoff C. Immunmodulatorische Wirkung der Bluttransfusion und Einfluß auf Infektionsrate und Tumorrezidiv. Infusionstherapie und Transfusionsmedizin 1997; 24: 20-31.
2. Fischer E, Lenhard V, Seifert P, Kluge A, Johannsen R. Blood transfusion-induced suppression of cellular immunity in man. Human Immunology 1980; 3: 187-194.
3. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M, Eissner HJ, Schildberg FW. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328-1333.
4. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. New England Journal of Medicine 1993; 328: 1372-1376.
5. Houbiers JGA, Brand A, van de Watering LMG, Hermans J, Verwey PJM, Bijnen AB, Pahlplatz P, Eeftinck-Schattenkerk M, Wobbes TH, de Vries JE, Klementschitsch P, van de Maas AHM, van de Velde CJH. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573-577.
6. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of Jeucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841-845.
7. Heiss MM, Fasol-Merten K, Allgayer H, Ströhlein MA, Tarabichi A, Wallner S, Eissner HJ, Jauch KW, Schildberg FW. Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox Sanguinis 1997; 73: 237-245.
8. Gantt CL. Red blood cells for cancer patients. Lancet 1981; ii: 363.
9. Heiss MM, Mempel W, Delanoff CH, Jauch KW, Gabka CH, Mempel M, Dieterich HJ, Eissner HJ, Schildberg FW. Blood transfusion - modulated tumor recurrence: First results of a randomized study of autologous vs. allogeneic blood transfusion in colorectal cancer surgery. Journal of Clinical Oncology 1994; 12: 1859-1867.
10. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. British Journal of Surgery 1993; 80: 427-432.
11. Vamvakas EC, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: A qualitative statistical overview and meta-analysis. Transfusion 1993; 33: 754-765.
12. Heiss MM, Allgayer H, Gruetzner KU, Tarabichi A, Babic R, Mempel W, Jauch KW, Schildberg FW. Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients. Anticancer Research 1997; 17: 2657-2662.
13. 2 and its role in the activation of T-suppressor cells. Transplantation Proceedings 1985; 17: 2380-2382.
14. Stephan RN, Kisala JM, Dean RE, Geha AS, Chaudry IH. Effect of blood transfusion on antigen presentation function and on interleukin-2 generation. Archives of Surgery 1988; 123: 235-240.
15. Kalechman Y, Gafter U, Sobelman D, Sredni B. The effect of a single whole-blood transfusion on cytokine secretion. Journal of Clinical Immunology 1990; 10: 99-105.
16. Ellis TM, Mohanakumar T, Muakkassa W, Lower RR, Lee HM. Influence of immunosuppressive therapy and blood transfusion on human T-cell subpopulations. Transplantation Proceedings 1983; 15: 1173-1175.
17. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984; 64: 308-310.
18. Schot JDL, Schuurman RKB. Blood transfusion suppresses cutaneous cell-mediated immunity. Clinical and Experimental Immunology 1986; 65: 336-344.
19. Waymack JP, McNeal N, Warden GD, Balakrishnan K, Gonce S, Alexander JW, Miskell P. Effect of blood transfusions on macrophage-lymphocyte interaction in an animal model. Annals of Surgery 1986; 204: 681-685.
20. Pohanka E, Manfro RC, Oto C, Colombe BW, Melzer J, Feduska N, Salvatierra O, Garovoy MR. Anti-idiotypic antibodies to HLA after donor-specific blood transfusion (DST). Transplantation Proceedings 1989; 21: 1806-1809.
21. Smith MD, Williams JD, Coles GA, Salaman JR. The effect of blood transfusion on T-suppressor cells in renal dialysis patients. Transplantation Proceedings 1981; 13: 181-183.
22. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991; 31: 212-217.
23. Triulzi DJ, Vanek K, Ryan DH, Blumberg N. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992; 32: 517-524.
24. Fernandez MC, Gottlieb M, Menitove JE. Blood transfusion and postoperative infection in orthopedic patients. Transfusion 1992; 32: 318-322.
25. Jensen LS, Andersen A, Fristrup SC, Holme JB, Hvid HM, Kraglund K, Rasmussen PC, Toftgaard C. Comparison of one dose versus three doses of prophylactic antibiotics, and the influence of blood transfusion, on infectious complications in acute and elective colorectal surgery. British Journal of Surgery 1990; 77: 513-518.
26. Vignali A, Braga M, Dionigi P, Radaelli G, Gentilini O, Bellini A, Jemos V, DiCarlo V. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer. European Journal of Surgery 1995; 161: 487-492.
27. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquer RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. New England Journal of Medicine 1993; 328: 1372-1376.
28. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841-845.
29. MacLeod AM, Mason RJ, Stewart KN, Power DA, Shewan WG, Edward N, Catto GRD. Fc-receptor blocking antibodies develop after blood transfusions and correlate with good graft outcome. Transplant Proceedings 1983; 15: 1019-1021.
30. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism and graft acceptance. Lancet 1992; 339: 1579-1582.